METiS Pharmaceuticals Alternatives & Competitors

12 companies similar to METiS Pharmaceuticals

Spirea

Elevating the Therapeutic Potential of ADCs in Cancer and Beyond with Our Unique Multivale...

8 Seed $2.40M

Cambridge, United Kingdom

Biotechnology Health Care +1

Nanoform

Nanoform uses platform technologies to develop innovative nanoparticle medicines, reducing...

Grant $46.30M

Helsinki, Finland

Biotechnology Pharmaceutical

Beihai Biotech

Putting Patients First, Innovation for All

1 Series C $300.00M

Biopharma Biotechnology +1

Rongcan Bio

Completing the entire nucleic acid industry cycle, from sequence design to drug delivery.

Series A $100.00M

Biopharma Biotechnology +1

Track all METiS Pharmaceuticals competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Evox Therapeutics Ltd

Changing the course of CNS disease

36 Series C $128.18M

Oxford, United Kingdom

Biotechnology Health Care +1

Sorintellis

AI-Powered Pharmaceutical Portfolio Management

Montreal, Canada

AI Biotechnology +3

Quince Therapeutics

Dedicated to unlocking the power of a patient’s own biology for the treatment of rare dise...

25 Post-IPO Equity

South San Francisco, Unit...

Biotechnology Health Care +1

Cerebral Therapeutics, Inc.

A clinical stage pharmaceutical company developing innovative treatments for neurological...

22 Series C $85.80M

Aurora, United States

Biotechnology Health Care +2

LinXis Biopharmaceuticals

We target the cells that drive fibrosis

Amsterdam, The Netherland...

Biotechnology Health Care +1

OncXerna Therapeutics

Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...

8 Venture round $126.50M

Waltham, United States

Biopharma Biotechnology +3

Autotelic Bio Inc.

RNA Therapeutics New Drug Development Company

15 Series B $22.00B

Korea South

Biotechnology Pharmaceutical

Tagworks Pharmaceuticals

Pioneer of Click-to-Release chemistry; designing more effective and safer systemic therapi...

47 Series A $65.00M

Nijmegen, The Netherlands

Biotechnology Health Care +1

About METiS Pharmaceuticals

METiS Pharmaceuticals, founded in 2020, is an innovative biotechnology company leveraging artificial intelligence (AI) to drive targeted drug delivery technology for developing more effective drugs. The firm integrates cutting-edge AI technology with traditional pharmaceutical R&D, aiming to accelerate the R&D of innov...

Business keywords

Drug Delivery, Pharmaceutical R&D, Innovation, AI Technology, Precision Medicine, Nucleic Acid Drug Development, Quantum Simulation, Targeted Drug Delivery, Innovative Drug Development, Precision Drug Design, Pharmaceutical Innovation

Frequently Asked Questions

Companies similar to METiS Pharmaceuticals include Spirea, Nanoform, Beihai Biotech, Rongcan Bio, Evox Therapeutics Ltd. They work in Biotechnology and Pharmaceutical and share METiS Pharmaceuticals's focus on precision medicine, drug delivery and targeted drug delivery.

Bounce Watch lists 12 companies that share METiS Pharmaceuticals's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches METiS Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

METiS Pharmaceuticals Profile Spirea Alternatives Nanoform Alternatives Beihai Biotech Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at METiS Pharmaceuticals on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.